A randomized, double-blind, placebo-controlled study of OROS methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

被引：0
|
作者：
Biederman, J [1 ]
Mick, E [1 ]
Surman, C [1 ]
Doyle, R [1 ]
Hammerness, P [1 ]
Harpold, T [1 ]
Dunkel, S [1 ]
Dougherty, M [1 ]
Aleardi, M [1 ]
Spencer, T [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S631 / S632
页数：2
相关论文
共 50 条
  • [1] A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
    Biederman, J
    Mick, E
    Surman, C
    Doyle, R
    Hammerness, P
    Harpold, T
    Dunkel, S
    Dougherty, M
    Aleardi, M
    Spencer, T
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (09) : 829 - 835
  • [2] A double-blind placebo-controlled randomized study of OROS methylphenidate in the treatment of adults with attention deficit hyperactivity disorder (ADHD): An interim analysis
    Biederman, J
    Spencer, T
    Surman, C
    Mick, E
    Dunkel, S
    Dougherty, M
    Aleardi, M
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 106S - 106S
  • [3] A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder
    Pliszka, SR
    Browne, RG
    Olvera, RL
    Wynne, SK
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (05): : 619 - 626
  • [4] Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation Study
    Adler, Lenard A.
    Zimmerman, Brenda
    Starr, H. Lynn
    Silber, Steve
    Palumbo, Joseph
    Orman, Camille
    Spencer, Thomas
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) : 239 - 247
  • [5] Solriamfetol for Attention-Deficit/ Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study
    Surman, Craig B. H.
    Walsh, Daniel M.
    Horick, Nora
    Disalvo, Maura
    Vater, Chloe Hutt
    Kaufman, Daniel
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (06) : 36 - 43
  • [6] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [7] A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder
    Greenhill, LL
    Findling, RL
    Swanson, JM
    [J]. PEDIATRICS, 2002, 109 (03) : E39
  • [8] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
    Kenneth S Koblan
    Seth C Hopkins
    Kaushik Sarma
    Fengbin Jin
    Robert Goldman
    Scott H Kollins
    Antony Loebel
    [J]. Neuropsychopharmacology, 2015, 40 : 2745 - 2752
  • [9] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
    Koblan, Kenneth S.
    Hopkins, Seth C.
    Sarma, Kaushik
    Jin, Fengbin
    Goldman, Robert
    Kollins, Scott H.
    Loebel, Antony
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (12) : 2745 - 2752
  • [10] Vitamin mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial
    Rucklidge, Julia J.
    Frampton, Chris M.
    Gorman, Brigette
    Boggis, Anna
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2014, 204 (04) : 306 - 315
12345